Sputum screening by quantitative microscopy: A reexamination of a portion of the national cancer institute cooperative early lung cancer study

Mayo Clinic Proceedings

Volumn 72, Issue 8, 1997, Pages 697-704

  Payne, Peter W ^a,c   Sebo, Thomas J ^a,b   Doudkine, Alexi ^a,b   Garner, David ^a,b   Macaulay, Calum ^a,b   Lam, Stephen ^a,b   Jean, C ^a,b   Palcic, Branko ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MAYO CLINIC ROCHESTER   (United States)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE CONTROL STUDY; COMPUTER ASSISTED DIAGNOSIS; CYTOLOGY; HEALTH CARE ORGANIZATION; HUMAN; LUNG TUMOR; MALE; MASS SCREENING; METHODOLOGY; MICROSCOPY; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPUTUM; SQUAMOUS CELL CARCINOMA; UNITED STATES;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MASS SCREENING; MICROSCOPY; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); ROC CURVE; SENSITIVITY AND SPECIFICITY; SPUTUM; UNITED STATES;

EID: 0031201298     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(11)63587-8     Document Type: Article

References (51)

1. American Cancer Society. Cancer Facts & Figures, 1995. Atlanta: American Cancer Society; 1995
2. Shields TW. Screening, staging, and diagnostic investigation of non-small cell lung cancer patients. Curr Opin Oncol 1991:3:297-305
3. Dillman RO, Berry C. Ryan KP, Green MR, Seagren SL. Recent outcomes for patients with carcinoma of the lung. Cancer Invest 1991;9:9-17
4. Ihde DC, Minna JD. Non-small cell lung cancer. Part I. Biology, diagnosis, and staging. Curr Probl Cancer 1991:15:61-104
5. Karsell PR, McDougall JC. Diagnostic tests for lung cancer. Mayo Clin Proc 1993:68:288-296
6. Saccomanno G, Archer VE, Auerbach O. Saunders RP. Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974:33:256-270
7. Eddy DM. Screening for lung cancer. Ann Intern Med 1989:111:232-237
8. Risse EK, Vooijs GP, van't Hof MA. Diagnostic significance of "severe dysplasia" in sputum cytology. Acta Cytol 1988:32:629-634
9. Grüner OC. A study of the changes met with in the leucocytes in certain cases of malignant disease. Br J Surg 1915-1916:3:506-525
10. Nieburgs HE. Zak FG, Alien DC, Reisman H, Clardy T. Systemic cellular changes in material from human and animal tissues in presence of tumors. In: Transactions of the 7th Annual Meeting of the Inter-Society Cytology Council: 1959. p 137
11. Holiday DB. McLarty JW. Parley ML, Mabry LC, Cozens D, Roby T, et al. Sputum cytology within and across laboratories: a reliability study. Acta Cytol 1995:39:195-206
12. Vooijs GP, van Aspert van Erp AJM, van't Hof Grootenboer BE, Klinkhamer PJJM. Intra- and interobserver variability. In: Wied GL. Keebler CM, Rosenthal DL, Schenck U, Somrak TM, Vooijs GP, editors. Compendium on Quality Assurance. Proficiency Testing and Workload Limitations in Clinical Cytology. Chicago: Tutorials of Cytology; 1995. pp 15-27
13. MacAulay C. Lam S, Payne P. Palcic B. Malignancy associated changes in epithelial cells from bronchial biopsies [abstract]. Chest 1993:103:2605
14. Nicolö G. Nieburgs HE, Margallo E. Morphometric analysis of malignancy-associated changes in ciliated bronchial cells [abstract]. Anal Quant Cytol Histol 1994:16:61
15. Montag AG. Bartels PH, Dytch HE, Lenna-Puertas E. Michelassi F, Bibbo M. Karyometric features in nuclei near colonie adenocarcinoma: statistical analysis. Anal Quant Cytol Histol 1991:13:159-167
16. Susnik B, Worth A, LeRicheJ. Palcic B. Malignancy-associated changes in the breast: changes in chromatin distribution in epithelial cells in normal-appearing tissue adjacent to carcinoma. Anal Quant Cytol Histol 1995:17:62-68
17. Montag AG. Bartels PH. Lerma-Puertas E. Dytch HE, Leelakusolvong S. Bibbo M. Karyometric marker features in tissue adjacent to in situ cervical carcinomas. Anal Quant Cytol Histol 1989:11:275-280
18. Bibbo M. Montag AG, Lerma-Puertas E. Dytch HE. Leelakusolvong S, Bartels PH. Karyometric marker features in tissue adjacent to invasive cervical carcinomas. Anal Quant Cytol Histol 1989:11:281 -285
19. Hutchinson ML, Isenstein LM, Martin JJ, Zahniser DJ. Measurement of subvisual changes in cervical squamous metaplastic cells for detecting abnormality. Anal Quant Cytol Histol 1992;4:330-334
20. Haroske G, Bergander S, Konig R. Frequency and diagnostic reliability of subvisual morphologic markers for malignancy in the cervical epithelium. Arch Geschwulstforsch 1988; 58:159-168
21. Kwikkel HJ, Timmers T, Boon ME, van Rijswijk MM, Stolk JG. Relation of quantitative features of visually normal intermediate cells in cervical intraepithelial neoplasia I and II smears to progression or nonprogression of the lesion. Anal Quant Cytol Histol 1987;9:405-410
22. Wied GL, Bibbo M, Pishotta FT, Bartels PH. Intermediate cell markers for malignancy: consistency of expression. Anal Quant Cytol 1984;6:243-246
23. Burger G, Jutting U, Rodenacker K. Changes in benign cell populations in cases of cervical cancer and its precursors. Anal Quant Cytol 1981;3:261-271
24. Palcic B, MacAulay C. Malignancy associated changes: can they be employed clinically? In: Wied GL, Bartels PH, Rosenthal DL, Schenck U, editors. Compendium on the Computerized Cytology and Histology Laboratory. Chicago: Tutorials of Cytology; 1994. pp 157-165
25. Jaggi B, Poon SSS, Pontifex B, Fengler JJP, Palcic B. Evaluation of a quantitative microscope for image cytometry. Excerpta Medica International Congress Series No. 911, 1990. pp31-32
26. Palcic B, MacAulay C, Shlien S, Treurniet W, Tezcan H, Andersen G. Comparison of three different methods for automated classification of cervical cells. Anal Cell Pathol 1992;4:429-441
27. MacAulay C, Garner D, Harrison A, Palcic B. Real or imaginary numbers: malignancy associated changes in an automated cervical smear screening system [abstract]. Anal Cell Pathol 1992;4:195
28. MacAulay C, Garner D, Harrison A, Palcic B. Separating the wheat from the chaff (automated cervical cell recognition) [abstract]. Anal Cell Pathol 1992;4:194-195
29. Garner DM, Harrison A, MacAulay C, Palcic B. Cyto-Savant and its use in automated screening of cervical smears. In: Wied GL, Bartels PH, Rosenthal DL, Schenck U, editors. Compendium on the Computerized Cytology and Histology Laboratory. Chicago: Tutorials of Cytology; 1994. pp 346352
30. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. JOccupMed 1986;28:746-750
31. Flehinger BJ, Kimmel M, Polyak T, Melamed MR. Screening for lung cancer: the Mayo Lung Project revisited. Cancer 1993;72:1573-1580
32. Martini N, Zaman MB, Melamed MR. Early diagnosis of carcinoma of the lung. In: Roth JA, Cox JD, Hong WK, editors. Lung Cancer. Boston: Blackwell Scientific; 1993. pp 133-141
33. Saccomanno G, Saunders RP, Ellis H, Archer VE, Wood BG, Beckler PA. Concentration of carcinoma or atypical cells in sputum. Acta Cytol 1963;7:305-310
34. Feulgen R, Rossenbeck H. Mikroskopischchemischer Nachweiseiner Nukleinsäure vom Typus der Thymonukleinsäure und die darauf beruhende elektive Färbung von Zellkernen in mikroskopischen Präparaten. Ztschr Physiol Chem 1924; 125:203-248
35. Tezcan A, Garner DM, Lam P, Korbelik J, Palcic B. Analysis of thionin, gallocyanin and hematoxylin for automated quantitative image cytometry of cervical samples [abstract]. In: Program and Abstracts of the 8th Annual Meeting, Clinical Applications of Cytometry; 1993 Sep 15-18; Charleston (SC)
36. Gurley AM, Hidvegi DF, Bacus JW, Bacus SS. Comparison of the Papanicolaou and Feulgen staining methods for DNA quantification by image analysis. Cytometry 1990; 11:468474
37. MacAulay C. Development, Implementation and Evaluation of Segmentation Algorithms for the Automated Classification of Cervical Cells. Thesis, University of British Columbia, 1989
38. Bengtsson E, Nordin B. Densitometry, morphometry, and textural analysis as tools in quantitative cytometry and automated cancer screening. In: Grohs HK, Nasseem Husain OA, editors. Automated Cervical Cancer Screening. New York: Igaku-Shoin; 1994. pp21-43
39. Doudkine A, MacAulay C, Poulin N, Palcic B. Nuclear texture measurements in image cytometry. Pathologica 1995;87:286-299
40. Melamed MR, Flehinger BJ, Zaman MB. Impact of early detection on the clinical course of lung cancer. Surg Clin North Am 1987 Oct;67:909-924
41. Melamed MR, Flehinger BJ. Screening for lung cancer [letter]. Ann Intern Med 1989;! 11:764-765
42. Tockman MS, Mulshine JL, Smart CR. Screening for lung cancer [letter]. Ann Intern Med 1989;! 11:765-766
43. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, et al. Screening for lung cancer: a critique of the Mayo Lung Project. Cancer 1991 ;67(Suppl): 1155-1164
44. Mulshine JL, Tockman MS, Smart CR. Considerations in the development of lung cancer screening tools. J Natl Cancer Inst 1989;81:900-906
45. Böcking A, Biesterfeld S, Châtelain R, Gien-Gerlach G, Esser E. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum: sensitivity and specificity of an alternative to routine cytology. Acta Cytol 1992;36:37-47
46. Anderson GH. Cytologie screening programs. In: Bibbo M, editor. Comprehensive Cytopathology. Philadelphia: Saunders; 1991. pp 48-58
47. Tockman MS, Gupta PK, Myers JD, Frost JK, Baylin SR, Gold EB, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J ClinOncol 1988;6:1685-1693
48. Greenberg SD, Spjut HJ, Estrada RG, Hunter NR, Grenia C. Morphometric markers for the evaluation of preneoplastic lesions in the lung: diagnostic evaluation by high-resolution image analysis of atypical cells in sputum specimens. Anal Quant Cytol Histol 1987;9:49-54
49. Greenberg SD. Diagnosis of sputum atypias by cell image analysis: a review. Surv Synth Pathol Res 1983;2:229234
50. Swank PR, Greenberg SD. Optical automation for sputum cytology. Appl Optics 1987;26:3373-3378
51. Band PR, Feldstein M, Saccomanno G. Reversibility of bronchial marked atypia: implications for chemoprevention. Cancer Detect Prev 1986;9:157-160